| (Values in U.S. Thousands) | Jun, 2021 | Mar, 2021 | Dec, 2020 | Sep, 2020 | Jun, 2020 |
| Sales | 5,070 | 0 | 30 | 680 | 530 |
| Sales Growth | unch | -100.00% | -95.59% | +28.30% | -36.90% |
| Net Income | 120 | -5,010 | -3,260 | -1,890 | -1,530 |
| Net Income Growth | +102.40% | -53.68% | -72.49% | -23.53% | +45.16% |
Exactus Inc (EXDI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Exactus, Inc. is a life science company. It engaged in developing and commercializing point-of-care diagnostics for measuring proteolytic enzymes in the blood. The company's lead product consists of FibriLyzer(TM) and MatriLyzer (TM). Exactus, Inc. is based in Richmond, Virginia.